SCHEMBL12440901

SCHEMBL12440901

Cc1ccc(-c2cc(Br)c(Br)c(Br)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.60
ALDH1A1 P00352 2/20 0.43
ACHE P22303 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MCL1 Q07820 1/20 0.35
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12128093 0.85 ALDH1A1 (0.43) APEX1ALDH1A1ACHETDP1CRHBP
SCHEMBL1048414 0.80 ALDH1A1 (0.43) APEX1ALDH1A1ACHETDP1MEN1
SCHEMBL4195128 0.78 ACHE (0.57) ALDH1A1ACHETDP1MEN1KMT2A
SCHEMBL19288252 0.78 ACHE (0.57) ALDH1A1ACHETDP1MEN1KMT2A
SCHEMBL7170676 0.78 APEX1 (1.00) APEX1TDP1CRHBPCRHR2MAPT
SCHEMBL15678841 0.77 ALDH1A1 (0.68) ALDH1A1ACHETDP1HPGDCYP2C19
SCHEMBL13072157 0.77 ALDH1A1 (0.68) ALDH1A1ACHETDP1HPGDCYP2C19
SCHEMBL1615060 0.77 ALDH1A1 (0.52) ALDH1A1ACHETDP1MEN1KMT2A
SCHEMBL1047357 0.77 ALDH1A1 (0.52) ALDH1A1ACHETDP1MEN1KMT2A
SCHEMBL12129699 0.76 ALDH1A1 (0.36) APEX1ALDH1A1ACHETDP1CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9318706-B2 Laminated structure, method for producing same, and electronic element comprising same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-19 US disclosed
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-21 US disclosed
US-20100069603-A1 METHOD FOR PRODUCING STRUCTURE WHEREIN AROMATIC POLYMER IS BONDED TO BASE, STRUCTURE HAVING AROMATIC POLYMER CHAIN BONDED TO CONDUCTIVE BASE, AND ELECTRONIC DEVICE COMPRISING THE STRUCTURE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME EPCAM, ITGA1, ITGB1 APEX1 1517/4885ALDH1A1 618/4885ACHE 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.